Clearside Biomedical Inc (CLSD)
1.30
+0.02
(+1.56%)
USD |
NASDAQ |
May 15, 15:36
Clearside Biomedical Free Cash Flow: -20.49M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -20.49M |
| December 31, 2023 | -19.91M |
| September 30, 2023 | -25.98M |
| June 30, 2023 | -25.81M |
| March 31, 2023 | -24.81M |
| December 31, 2022 | -13.61M |
| September 30, 2022 | -2.859M |
| June 30, 2022 | 0.204M |
| March 31, 2022 | -1.303M |
| December 31, 2021 | -10.73M |
| September 30, 2021 | -20.22M |
| June 30, 2021 | -19.61M |
| March 31, 2021 | -15.88M |
| December 31, 2020 | -13.18M |
| September 30, 2020 | -7.05M |
| June 30, 2020 | -10.44M |
| March 31, 2020 | -17.28M |
| Date | Value |
|---|---|
| December 31, 2019 | -27.09M |
| September 30, 2019 | -53.10M |
| June 30, 2019 | -66.80M |
| March 31, 2019 | -76.31M |
| December 31, 2018 | -79.29M |
| September 30, 2018 | -70.07M |
| June 30, 2018 | -63.76M |
| March 31, 2018 | -55.76M |
| December 31, 2017 | -51.39M |
| September 30, 2017 | -42.75M |
| June 30, 2017 | -35.68M |
| March 31, 2017 | -29.60M |
| December 31, 2016 | -22.71M |
| September 30, 2016 | -20.11M |
| June 30, 2016 | -16.88M |
| March 31, 2016 | -14.58M |
| December 31, 2015 | -13.90M |
Free Cash Flow Range, Past 5 Years
-66.80M
Minimum
Jun 2019
0.204M
Maximum
Jun 2022
-19.80M
Average
-18.44M
Median
Free Cash Flow Benchmarks
| Cassava Sciences Inc | -87.90M |
| Heron Therapeutics Inc | -43.40M |
| Actinium Pharmaceuticals Inc | -39.72M |
| Karyopharm Therapeutics Inc | -117.73M |
| Ocular Therapeutix Inc | -87.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.851M |
| Cash from Investing (Quarterly) | -0.057M |
| Cash from Financing (Quarterly) | 14.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1132 |
| Free Cash Flow to Equity (Quarterly) | -7.908M |
| Free Cash Flow Yield | -24.64% |